The Complete Guide

Sildenafil (Generic Viagra): The Complete Guide

How it was discovered, how it actually works, and everything worth knowing before you order it.

Complete Guide · ~20 min read · Last updated July 2026

What Sildenafil Actually Is

Sildenafil citrate is a PDE5 inhibitor — a compound that blocks an enzyme called phosphodiesterase type 5, which otherwise breaks down a molecule called cyclic GMP in smooth muscle tissue. Block the enzyme, and cyclic GMP sticks around longer, which keeps blood vessels relaxed and open in response to sexual stimulation. It's the same active ingredient sold under the brand name Viagra®, and the most recognized ED medication in the world by a wide margin — recognized enough that the brand name itself became a byword for the entire category, and eventually a verb, in a way few pharmaceutical products ever achieve.

On this site, sildenafil is the catalog's flagship listing, sold as Sildatron-100. Every generic sildenafil product, regardless of manufacturer or trade name, contains the identical active molecule — the differences between products come down to manufacturer, regulatory pathway, and inactive ingredients, not the compound doing the actual work.

The Accidental Discovery

Sildenafil's origin story is one of the better-known accidents in modern pharmaceutical history, and it's worth telling in full because it explains several things about the drug that otherwise seem like unrelated trivia. In 1986, researchers at Pfizer's laboratories in Sandwich, England, identified a class of compounds — pyrazolopyrimidines — as potent, selective inhibitors of PDE5, as part of a research program aimed squarely at angina, a form of chest pain caused by reduced blood flow to the heart. Pfizer's Sandwich site already had a track record with cardiovascular drugs; earlier work there had produced prazosin, doxazosin, and amlodipine, all established blood-pressure medications. Sildenafil, initially designated UK-92,480, was a natural extension of that research pipeline, not a speculative side project.

The compound moved into clinical development for cardiovascular disease in 1989, and a Phase I study for angina began the following year. By 1992, the first and only Phase II trial of sildenafil as an anti-anginal agent found only moderate effects on the cardiovascular measures the trial was actually designed to test. As a heart drug, in other words, sildenafil was underwhelming — by the early 1990s, its future in that indication looked doubtful.

What kept the compound alive was a side effect nobody had been looking for. Male trial participants — largely recruited in Wales for the cardiovascular studies — reported an unexpected and persistent effect: erections, at a rate and reliability the research team felt obliged to formally document rather than dismiss as noise. That documentation reached Pfizer's senior research leadership and prompted a reconsideration of what the compound might actually be useful for. Researchers Peter Ellis and Nick Terrett recognized the underlying mechanistic link: nitric oxide is a key regulator of vascular tone specifically in the corpus cavernosum, the erectile tissue of the penis, and a PDE5 inhibitor would amplify that exact pathway. It wasn't a coincidence that a vasodilator developed for one blood vessel bed turned out to have a dramatic effect on another — it was the same biochemistry, applied to different tissue.

Clinical trials specifically for erectile dysfunction began in the early 1990s. A 1994 pilot study found that a single dose was able to induce erections in study participants — a striking, fast-moving confirmation of what the angina trial reports had suggested. By 1997, 21 separate clinical trials had demonstrated sildenafil's efficacy for ED across a range of patient populations. The FDA approved it — as Viagra — in 1998, the first oral treatment for erectile dysfunction ever approved by the agency, granted under a priority review given the lack of any existing oral alternative.

How It Actually Works

Sexual stimulation triggers the release of nitric oxide in the tissue of the penis, which activates an enzyme called guanylate cyclase, which in turn produces a molecule called cyclic GMP. Cyclic GMP is the actual signal responsible for relaxing smooth muscle in the arteries and erectile tissue, allowing increased blood flow in and reduced outflow — the physical basis of an erection. Under normal circumstances, an enzyme called phosphodiesterase type 5, or PDE5, breaks cyclic GMP back down fairly quickly, which ends the signal and allows the tissue to return to its resting state.

Sildenafil's entire mechanism is built around blocking PDE5. With the breakdown enzyme inhibited, cyclic GMP persists longer once it's produced, which sustains the relaxation and blood-flow response for longer than it would occur naturally. This is the single most important thing to understand about how sildenafil — and every PDE5 inhibitor in this catalog — actually works: it doesn't generate the initial signal. Sexual stimulation still has to trigger the nitric oxide release in the first place. Sildenafil amplifies and extends a response that has to start somewhere else. That's why the medication doesn't cause spontaneous, unprompted erections in the way popular culture sometimes implies, and it's central to why studies haven't found meaningful benefit from these drugs in men whose erectile function is already normal — there's no baseline signal deficiency for the drug to compensate for.

Strength and Dosing

Sildenafil is typically available across a 25mg to 100mg range, and it's exclusively an as-needed medication — there's no low-dose daily sildenafil regimen the way there is for tadalafil, where a much smaller daily dose is a genuinely separate, prescriber-managed approach. Sildatron-100, the catalog's flagship listing, sits at the top of the sildenafil range, full strength, which makes it the natural product for someone who already knows 100mg works for them, and a less obviously conservative starting point for someone taking a PDE5 inhibitor for the first time.

The logic behind starting conservative isn't about safety thresholds so much as information — a prescriber writing a first sildenafil prescription generally can't predict in advance exactly how a given patient will respond, so starting in the middle of the range and adjusting based on actual results is the more common clinical default than jumping straight to the maximum dose. Ordering without a prescriber involved doesn't remove the logic of that approach; it just means the responsibility for applying it shifts to you. Our full sildenafil strength guide covers this decision framework in more depth, and our pack-size pricing guide explains how ordering a smaller quantity first, regardless of strength, keeps your first order lower-risk in a financial sense too.

Onset, Duration, and Food Interactions

Sildenafil's effects are commonly discussed in terms of a multi-hour window — meaningfully shorter than tadalafil's substantially longer duration, which is part of why the two drugs get used differently even though they belong to the same class. Absorption is affected by food in a way that's worth planning around: a high-fat meal taken close to a dose has historically been associated with slower absorption and a delayed onset. This isn't unique to sildenafil among medications — fat content in the stomach genuinely slows the absorption of a number of oral drugs — but it's specific and well-documented enough for sildenafil that it's worth knowing before you time a dose around a meal.

A less commonly known but real pharmacological interaction involves grapefruit. Grapefruit and grapefruit juice inhibit an enzyme called CYP3A4, which is involved in metabolizing and clearing sildenafil from the body. Inhibiting that enzyme can increase how much of the active drug remains in circulation and for how long — effectively increasing exposure beyond what the stated dose would normally produce. This is a genuine, if often overlooked, food-drug interaction that applies to a range of medications beyond sildenafil, and it's worth being aware of specifically because grapefruit is common enough in an ordinary diet that people don't always think to mention it when discussing medication interactions with a doctor or pharmacist.

Sildenafil Beyond ED

Sildenafil's very first intended use was cardiovascular, and the molecule never fully left that world after ED became its dominant public identity. Under the brand name Revatio, sildenafil is FDA-approved for pulmonary arterial hypertension (PAH) in adults — a serious, progressive condition involving high blood pressure specifically in the arteries supplying the lungs, distinct from ordinary systemic high blood pressure. The mechanism is the same PDE5-inhibition pathway that treats ED, applied to a different vascular bed: relaxing and dilating the pulmonary arteries specifically, reducing the strain on the heart's right side that PAH otherwise causes. There have also been dedicated pediatric PAH studies evaluating sildenafil's safety and efficacy in children with the condition, using weight-based dosing distinct from anything relevant to this catalog.

Separately, and considerably more off-label from a regulatory standpoint, sildenafil has been used in neonatal intensive care to treat persistent pulmonary hypertension of the newborn (PPHN) — a related but distinct condition affecting newborns whose circulatory system fails to transition normally at birth. This use is particularly documented in settings without ready access to the standard first-line PPHN treatment, inhaled nitric oxide, including many hospitals in lower-resource countries. We cover this specific use in full — including the FDA's separate warning about long-term, high-dose sildenafil in older pediatric pulmonary hypertension patients, which is a meaningfully different clinical scenario from acute newborn treatment — in our dedicated sildenafil and newborns article.

Safety and the Nitrate Warning

Beyond nitrates, alpha-blockers — a class of medication sometimes prescribed for high blood pressure or an enlarged prostate — and certain other blood pressure medications can also interact with sildenafil, generally through an additive blood-pressure-lowering effect rather than the more acute nitrate interaction. Common, generally mild side effects reported with sildenafil include headache, flushing, nasal congestion, and indigestion — largely explained by the same vasodilating mechanism responsible for the drug's intended effect, just occurring in blood vessels elsewhere in the body. Our full ED medication safety guide covers the complete interaction picture across the entire catalog, not just sildenafil specifically.

Sildatron-100: The Catalog Listing

Sildatron-100 is a generic sildenafil citrate 100mg tablet — the catalog's most-ordered product and the natural entry point for anyone comparing generic sildenafil options. Full detail, including exact pricing and pack-size structure, is in our dedicated Sildatron-100 guide. Because 100mg is the top of the typical sildenafil dosing range, it's worth pairing that guide with our strength selection guide before ordering if this is your first time trying the compound at all — the catalog's flagship listing isn't automatically the right starting strength for every reader.

What to expect and what's worth mentioning to a doctor

Most people who take sildenafil experience mild or no side effects. When side effects do occur, they tend to track directly with the drug's vasodilating mechanism: headache and facial flushing from increased blood flow near the skin's surface, nasal congestion from swelling in nasal blood vessels, and occasionally visual disturbances like a blue-tinted haze or increased light sensitivity, which are generally temporary and resolve as the drug clears the system. Persistent or severe side effects, chest pain, vision loss, or an erection lasting more than four hours are all reasons to seek medical attention rather than waiting it out — the last of these, priapism, is rare but is a recognized medical emergency for any PDE5 inhibitor.

How Sildenafil Differs From the Other Three

Sildenafil, tadalafil, vardenafil, and avanafil are all PDE5 inhibitors with the same core mechanism, but they're distinct molecules with genuinely different pharmacokinetic profiles — this isn't four versions of the same drug with different names. Sildenafil's defining characteristics relative to the others: a shorter duration than tadalafil (hours rather than up to 36 hours), no daily-dose regimen option the way tadalafil has, and the most food-sensitive absorption profile of the group, given the well-documented high-fat-meal delay. Vardenafil sits pharmacokinetically closer to sildenafil than to tadalafil — similarly as-needed, similarly shorter-duration — while avanafil is generally cited as having the fastest onset of the four alongside a shorter half-life. If you're deciding between all four, our brand-name decoder lays out active ingredient, strength, and starting price for the full catalog side by side, and our dedicated guides on tadalafil and vardenafil and avanafil go deeper on each.

Myths About Sildenafil, Specifically

Two misconceptions come up often enough to name directly. First: that sildenafil works instantly regardless of stimulation — it doesn't; the mechanism still depends on the body's own arousal response being triggered first, and the drug amplifies that response rather than generating it independently. Second: that a higher dose is simply "more effective" — strength and effectiveness aren't the same axis, and 100mg isn't a better starting point than 25 or 50mg just because it's the maximum available strength; if anything, a new user has more information to gain from starting lower and observing the response than from starting at the ceiling. Our full mythbusting roundup covers these and more across the entire catalog.

Frequently Asked Questions